| Literature DB >> 21610250 |
Michael O Hottiger1, Mark Boothby, Friedrich Koch-Nolte, Bernhard Lüscher, Niall M B Martin, Ruth Plummer, Zhao-Qi Wang, Mathias Ziegler.
Abstract
Adenosine 5'-diphosphate (ADP)-ribosylation is a protein posttranslational modification that is catalyzed by ADP-ribosyltransferases (ARTs), using nicotinamide adenine dinucleotide (NAD(+)) as a substrate. Mono-ribosylation can be extended into polymers of ADP-ribose (PAR). Poly(ADP-ribosyl)polymerase (PARP) 1, the best-characterized cellular enzyme catalyzing this process, is the prototypical member of a family of mono- and poly(ADP-ribosyl)transferases. The physiological consequences of ADP-ribosylation are inadequately understood. PARP2010, the 18th International Conference on ADP-Ribosylation, attracted scientists from all over the world to Zurich, Switzerland. Highlights from this meeting include promising clinical trials with PARP inhibitors and new insights into cell, structural, and developmental biology of ARTs and the (glyco)hydrolase proteins that catalyze de-ADP-ribosylation of mono- or poly-ADP-ribosylated proteins. Moreover, potential links to the NAD-dependent sirtuin family were explored on the basis of a shared dependence on cellular NAD(+) concentrations and the relationship of ADP-ribosylation with intermediary metabolism and cellular energetics.Entities:
Mesh：
Substances：
Year: 2011 PMID： 21610250 DOI： 10.1126/scisignal.2001645
Source DB: PubMed Journal: Sci Signal ISSN： 1945-0877 Impact factor: 8.192